Diana et al. reported that FOXO3a competed with TCF for binding to β-catenin, thereby inhibiting TCF transcriptional activity and suppressing endogenous TCF target genes in colon carcinoma cells [25]. Here, FOXO3 is linked to colon carcinoma.